Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
Pre-Market Last Trade |
Last: $ 21.50 ▲ 0.55 (2.63%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 20.95 | 0.00 | 0.00 | 0.00 | 20.95 | 08:42:24 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 21.30 | 24.79 | 3.49 | 14.08% | - | - |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 4 | 460 | 1,212,685 | 7.26 - 26.59 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:13:13 | formt | 200 | $ 21.50 | USD |
Iovance Biotherapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.59B | 123.83M | $ -123.58M | -1.27 | - | 102.81M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.98 | 22.25 | 19.7205 | 20.8425 | 1M | -1.03 | -4.69% |
| 1 Month | 25.7 | 26.35 | 19.7205 | 23.1512 | 1M | -4.75 | -18.48% |
| 3 Months | 17.27 | 26.59 | 16.124 | 21.7401 | 2M | 3.68 | 21.31% |
| 6 Months | 10.36 | 26.59 | 9.21 | 17.1335 | 2M | 10.59 | 102.22% |
| 1 Year | 14.65 | 26.59 | 7.26 | 14.1483 | 1M | 6.3 | 43.00% |
| 3 Years | 9.18 | 26.59 | 4.45 | 13.1030 | 847k | 11.77 | 128.21% |
| 5 Years | 8.57 | 26.59 | 4.24 | 12.1497 | 717k | 12.38 | 144.46% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc operates in the healthcare sector based in the United States. It is a pharmaceutical manufacturer attending to serious diseases such as cancer. The Company's lead pipeline candidate, LN-144, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. The TIL therapy involves growing a patient's special culture conditions outside the patient's body, or ex vivo, and then infusing the T cells back into the patient. |
